Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF MARCH 01, 2019 FBO #6307
SOLICITATION NOTICE

66 -- PermaLife Cell Culture Bag

Notice Date

2/27/2019
 

Notice Type

Combine Synopsis/Solicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

6707 Democracy Blvd, Suite 106, MSC 5480 Bethesda MD 20892-5480
 

ZIP Code

20892-5480
 

Solicitation Number

19006498
 

Response Due

3/13/2019
 

Archive Date

3/14/2019
 

Point of Contact

Andre M. Moody, Contract Specialist, Phone 3014022677, Fax 3025945915
 

E-Mail Address

moodya@cc.nih.gov
 

Small Business Set-Aside

N/A
 

Description

This is a notice of intent, not a request for a quotation. A solicitaiton document will not be issued and quotations will not be requested. The Government intends to award a fixed price purchase order to Origen Biomedical, Inc., Austin, Texas 78744. The Department of Transfusion Medicine (DTM) at the National Institutes of Health (NIH) Clinical Center (CC), Bethesda, MD has a requirement to procure the supplies listed below: 1. PL30-2G Permalife Cell Culture Bag 30ml 400 each 2. PL07-2G Permalife Cell Culture Bag 7ml 20 each 3. PL120-2G Permalife Cell Culture Bag 120ml 130 each 4. PC2-B Protective Cap for female luer 100 each 5. PL240-2G Permalife Cell Culture Bag 240 50 each 6. PL325-2G Permalife Cell Culture Bag 325ml 150 each 7. PL70-2G Permalife Cell Culture Bag 70ml 60 each The Center for Cellular Engineering (CCE), Department of Transfusion Medicine, NIH Clinical Center (CC) is an AABB accredited cellular therapy laboratory whose central mission is to provide services to the NIH Institutes to support their intramural clinical trials. These services include (1) performing research aimed at development, evaluation and validation of new manufacturing processes for cellular therapies (2) manufacture of cellular therapy products for approved clinical trials. The majority of these trials are early phase (l/ll) trials not intended to result in the development of a commercial product. CCE produces clinical therapies from cells collectd from NIH CC patients and healthy donors. The product manufactured in this project by the laboratory is retinal pigment epithelium (RPE) generated from patient's blood cells. this product (RPE) will be used to treat age-related manufacturing process of this product. RPE will be manufactured using US Food and Drug Administration (FDA) guidelines for good manufacturing practices (GMP). It will require review and approval for use as an investigational new drug (IND) by the FDA. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (27-FEB-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
 

Web Link

Link To Document
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/19006498/listing.html)
 

Place of Performance

Address: 6707 Democracy Blvd. Suite 106 Bethesda, MD

Zip Code: 20892

Country: US
 

Record

SN05234907-F 20190301/190227230039 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |